Litigation Details for Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)
✉ Email this page to a colleague
Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-01-11 |
Court | District Court, N.D. California | Date Terminated | 2018-06-11 |
Cause | 28:2201 Declaratory Judgement | Assigned To | Jeffrey Steven White |
Jury Demand | None | Referred To | |
Patents | 7,485,704; 7,682,612; 7,807,799; 7,820,161; 7,976,838; 8,206,711; 8,329,172; 8,512,983; 8,545,843; 8,557,244; 8,821,873; 9,296,821; 9,428,548; 9,504,744; 9,714,293 | ||
Firms | Goodwin Procter LLP; Irell & Manella LLP | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Celltrion, Inc. v. Genentech, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-01-11 | 1 | U.S. Patent No. 7,390,660 (“the ’660 patent”); 2 U.S. Patent No. 7,485,704 (“the ’704 …right to enforce the ’660 patent. 15 U.S. Patent No. 7,485,704 (Exhibit 10), titled “Reducing…Declaratory Judgment of Non-Infringement of U.S. Patent No. 7,485,704 5 Plaintiffs restate …6,610,516; 6,620,918; 21 6,716,602; 7,390,660; 7,485,704; 7,682,612; 7,807,799; 7,820,161; 7,923,221; 8,044,017…704 patent”); 3 U.S. Patent No. 7,682,612 (“the ’612 patent”); 4 U.S. Patent No. 7,807,799 | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |